ReTaMed ApS: Financial statements 2025
CVR: 39608405
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
ReTaMed ApS (CVR 39608405) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,022 compared with DKK -861 the year before. Equity in the 2025 report amounted to DKK 50,000. The solvency ratio was 69%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,022
- Equity
- DKK 50,000
- Total Assets
- DKK 72,455
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | -1 t. | 50 t. | - |
| 2024 | - | 0 | -861 | 101 t. | - |
| 2023 | - | -14 t. | -8 t. | 101 t. | - |
| 2022 | - | -18 t. | -13 t. | 108 t. | 0 |
| 2021 | - | -60 t. | -57 t. | 121 t. | 1 |
Official annual report
How creditworthy is ReTaMed ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
ReTaMed ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK -861.
About ReTaMed ApS
ReTaMed ApS is a Danish company of the type Anpartsselskab based in Esbjerg, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Henrik Fomsgaard-Knudsen. The company is owned by ReTaMed Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,022 compared with DKK -861 the year before. Equity in the 2025 report amounted to DKK 50,000.